Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
BioLargo ( (BLGO) ) has provided an announcement.
At its 2025 annual stockholder meeting on June 19, 2025, BioLargo, Inc. announced the approval of all proposals, including the election of board members and the authorization for a potential reverse stock split. Although the reverse stock split was approved, the board has no immediate plans to implement it, intending to do so only if necessary for uplisting to a national exchange. CEO Dennis Calvert highlighted the company’s strategic positioning and readiness to expand its market reach and attract institutional investors when conditions are favorable.
Spark’s Take on BLGO Stock
According to Spark, TipRanks’ AI Analyst, BLGO is a Neutral.
BioLargo’s revenue growth is a positive indicator, but consistent losses and negative cash flow are significant concerns impacting financial stability. The technical indicators suggest bearish momentum, while valuation metrics show challenges due to negative earnings.
To see Spark’s full report on BLGO stock, click here.
More about BioLargo
BioLargo, Inc. is a cleantech and life sciences company that provides engineering services and innovative solutions to address environmental and cleantech challenges. Their core products focus on PFAS contamination, advanced water and wastewater treatment, odor and VOC control, air quality improvement, energy efficiency, safe on-site energy storage, and infection control. BioLargo aims to maximize the impact of its technologies through licensing and partnerships.
Average Trading Volume: 317,685
Technical Sentiment Signal: Strong Sell
Current Market Cap: $64.02M
For a thorough assessment of BLGO stock, go to TipRanks’ Stock Analysis page.